Trials / Sponsors / Shattuck Labs, Inc.
Shattuck Labs, Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase 1 Study of SL-325 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2025-09-01 |
| Completed | Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer | Phase 1 | 2022-08-18 |
| Terminated | Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | 2022-03-17 |
| Terminated | Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Ne Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck | Phase 1 | 2020-09-17 |
| Completed | Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | Phase 1 | 2020-06-29 |
| Completed | SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer | Phase 1 | 2019-03-26 |